Progress in research on the association between lifestyle and cardiometabolic multimorbidity

HAN Yu-ting; SUN Zhi-jia; LYU Jun; LI Li-ming

doi:10.16462/j.cnki.zhjbkz.2021.03.004

Volume 25 Issue 3

Mar. 2021

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2021 > 25(3): 266-270

HAN Yu-ting, SUN Zhi-jia, LYU Jun, LI Li-ming. Progress in research on the association between lifestyle and cardiometabolic multimorbidity[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2021, 25(3): 266-270. doi: 10.16462/j.cnki.zhjbkz.2021.03.004

Citation:

HAN Yu-ting, SUN Zhi-jia, LYU Jun, LI Li-ming. Progress in research on the association between lifestyle and cardiometabolic multimorbidity[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2021, 25(3): 266-270. doi: 10.16462/j.cnki.zhjbkz.2021.03.004

Citation:

PDF( 834 KB)

Progress in research on the association between lifestyle and cardiometabolic multimorbidity

doi: 10.16462/j.cnki.zhjbkz.2021.03.004

HAN Yu-ting¹,
SUN Zhi-jia¹,
LYU Jun^{1, 2},
LI Li-ming^{1, 2
,
,}

1.
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
2.
Peking University Center for Public Health and Epidemic Preparedness and Response, Beijing 100191, China

Funds:

National Natural Science Foundation of China 81941018

More Information

Corresponding author: LI Li-ming, E-mail: lmleeph@vip.163.com
Received Date: 2021-01-19
Rev Recd Date: 2021-02-09
Publish Date: 2021-03-10

Abstract

Abstract

Multimorbidity is common among the aging population. It significantly decreases the quality of life and increases the complexity and costs for disease treatment and management. With the acceleration of population aging, multimorbidity has gradually become the main threat to health. Prior studies have demonstrated that some diseases often co-occur due to shared risk factors and pathogenic pathways. Cardiometabolic multimorbidity is one of the most common and stable multimorbidity profiles. Adherence to a healthy lifestyle, as a crucial way for health management and disease management, has proven to be efficient for preventing single cardiometabolic diseases. In recent years, researchers have been exploring the association between lifestyle factors and the risk of cardiometabolic multimorbidity. In this article, the definition, distribution, and mechanism of cardiometabolic multimorbidity are reviewed and current evidence from prospective studies on association for the combined lifestyle factors with cardiometabolic multimorbidity is discussed.
- Lifestyle,
- Cardiometabolic disease,
- Multimorbidity,
- Association study

FullText(HTML)

References(41)

References

[1]	Han YT, He Y, Lv J, et al. Aging in China: perspectives on public health[J]. Global Health Journal, 2020, 4(1): 11-17. DOI: 10.1016/j.glohj.2020.01.002.
[2]	Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies[J]. PLoS One, 2014, 9(7): e102149. DOI: 10.1371/journal.pone.0102149.
[3]	The Academy of Medical Sciences. Multimorbidity: a priority for global health research[R]. The Academy of Medical Sciences, 2018. https://acmedsci.ac.uk/policy/policy-projects/multimorbidity.
[4]	Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature[J]. Ageing Res Rev, 2011, 10(4): 430-439. DOI: 10.1016/j.arr.2011.03.003.
[5]	Smith SM, Soubhi H, Fortin M, et al. Managing patients with multimorbidity: systematic review of interventions in primary care and community settings[J]. BMJ, 2012, 345: e5205. DOI: 10.1136/bmj.e5205.
[6]	Blakely T, Kvizhinadze G, Atkinson J, et al. Health system costs for individual and comorbid noncommunicable diseases: an analysis of publicly funded health events from New Zealand[J]. PLoS Med, 2019, 16(1): e1002716. DOI: 10.1371/journal.pmed.1002716.
[7]	Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, et al. Multimorbidity patterns: a systematic review[J]. J Clin Epidemiol, 2014, 67(3): 254-266. DOI: 10.1016/j.jclinepi.2013.09.021.
[8]	Busija L, Lim K, Szoeke C, et al. Do replicable profiles of multimorbidity exist? Systematic review and synthesis[J]. Eur J Epidemiol, 2019, 34(11): 1025-1053. DOI: 10.1007/s10654-019-00568-5.
[9]	Emerging Risk Factors Collaboration, Di Angelantonio E, Kaptoge S, et al. Association of cardiometabolic multimorbidity with mortality[J]. JAMA, 2015, 314(1): 52-60. DOI: 10.1001/jama.2015.7008.
[10]	Freisling H, Viallon V, Lennon H, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study[J]. BMC Med, 2020, 18(1): 5. DOI: 10.1186/s12916-019-1474-7.
[11]	Kang YM, Cho YK, Lee SE, et al. Cardiovascular diseases and life expectancy in adults with type 2 diabetes: a Korean national sample cohort study[J]. J Clin Endocrinol Metab, 2017, 102(9): 3443-3451. DOI: 10.1210/jc.2017-00643.
[12]	Kivimäki M, Kuosma E, Ferrie JE, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe[J]. Lancet Public Health, 2017, 2(6): e277-e285. DOI: 10.1016/s2468-2667(17)30074-9.
[13]	Singh-Manoux A, Fayosse A, Sabia S, et al. Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: a cohort study[J]. PLoS Med, 2018, 15(5): e1002571. DOI: 10.1371/journal.pmed.1002571.
[14]	Xu X, Mishra GD, Dobson AJ, et al. Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: a 20-year cohort study[J]. PLoS Med, 2018, 15(3): e1002516. DOI: 10.1371/journal.pmed.1002516.
[15]	Zhang D, Tang X, Shen P, et al. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study[J]. BMJ Open, 2019, 9(3): e024476. DOI: 10.1136/bmjopen-2018-024476.
[16]	Krokstad S, Ding D, Grunseit AC, et al. Multiple lifestyle behaviours and mortality, findings from a large population-based Norwegian cohort study-The HUNT Study[J]. BMC Public Health, 2017, 17(1): 58. DOI: 10.1186/s12889-016-3993-x.
[17]	Rosen H. Is obesity a disease or a behavior abnormality? Did the AMA get it right?[J]. Mo Med, 2014, 111(2): 104-108.
[18]	Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond[J]. Circulation, 2010, 121(4): 586-613. DOI: 10.1161/circulationaha.109.192703.
[19]	Eguchi E, Iso H, Tanabe N, et al. Is the association between healthy lifestyle behaviors and cardiovascular mortality modified by overweight status? The Japan Collaborative Cohort Study[J]. Prev Med, 2014, 62: 142-147. DOI: 10.1016/j.ypmed.2013.12.004.
[20]	Li Y, Ley SH, Tobias DK, et al. Birth weight and later life adherence to unhealthy lifestyles in predicting type 2 diabetes: prospective cohort study[J]. BMJ, 2015, 351: h3672. DOI: 10.1136/bmj.h3672.
[21]	Agha G, Loucks EB, Tinker LF, et al. Healthy lifestyle and decreasing risk of heart failure in women: the Women's Health Initiative observational study[J]. J Am Coll Cardiol, 2014, 64(17): 1777-1785. DOI: 10.1016/j.jacc.2014.07.981.
[22]	Sakakibara BM, Obembe AO, Eng JJ. The prevalence of cardiometabolic multimorbidity and its association with physical activity, diet, and stress in Canada: evidence from a population-based cross-sectional study[J]. BMC Public Health, 2019, 19(1): 1361. DOI: 10.1186/s12889-019-7682-4.
[23]	Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775, 385 individuals and 12, 539 strokes[J]. Lancet, 2014, 383(9933): 1973-1980. DOI: 10.1016/S0140-6736(14)60040-4.
[24]	Paneni F, Beckman JA, Creager MA, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part Ⅰ[J]. Eur Heart J, 2013, 34(31): 2436-2443. DOI: 10.1093/eurheartj/eht149.
[25]	Mozaffarian D, Marfisi R, Levantesi G, et al. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors[J]. Lancet, 2007, 370(9588): 667-675. DOI: 10.1016/S0140-6736(07)61343-9.
[26]	Thompson PD, Panza G, Zaleski A, et al. Statin-associated side effects[J]. J Am Coll Cardiol, 2016, 67(20): 2395-2410. DOI: 10.1016/j.jacc.2016.02.071.
[27]	Lv J, Yu C, Guo Y, et al. Adherence to a healthy lifestyle and the risk of type 2 diabetes in Chinese adults[J]. Int J Epidemiol, 2017, 46(5): 1410-1420. DOI: 10.1093/ije/dyx074.
[28]	Lv J, Yu C, Guo Y, et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population[J]. J Am Coll Cardiol, 2017, 69(9): 1116-1125. DOI: 10.1016/j.jacc.2016.11.076.
[29]	D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study[J]. Circulation, 2008, 117(6): 743-753. DOI: 10.1161/CIRCULATIONAHA.107.699579.
[30]	Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, et al. Hypertension and diabetes mellitus: coprediction and time trajectories[J]. Hypertension, 2018, 71(3): 422-428. DOI: 10.1161/HYPERTENSIONAHA.117.10546.
[31]	Qi Q, Liang L, Doria A, et al. Genetic predisposition to dyslipidemia and type 2 diabetes risk in two prospective cohorts[J]. Diabetes, 2012, 61(3): 745-752. DOI: 10.2337/db11-1254.
[32]	Bell JA, Hamer M, Batty GD, et al. Incidence of metabolic risk factors among healthy obese adults: 20-year follow-up[J]. J Am Coll Cardiol, 2015, 66(7): 871-873. DOI: 10.1016/j.jacc.2015.06.014.
[33]	Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes[J]. Lancet, 2017, 389(10085): 2239-2251. DOI: 10.1016/s0140-6736(17)30058-2.
[34]	Tune JD, Goodwill AG, Sassoon DJ, et al. Cardiovascular consequences of metabolic syndrome[J]. Transl Res, 2017, 183: 57-70. DOI: 10.1016/j.trsl.2017.01.001.
[35]	Zhang Y, Pan XF, Chen J, et al. Combined lifestyle factors and risk of incident type 2 diabetes and prognosis among individuals with type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies[J]. Diabetologia, 2020, 63(1): 21-33. DOI: 10.1007/s00125-019-04985-9.
[36]	Liu G, Li Y, Hu Y, et al. Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus[J]. J Am Coll Cardiol, 2018, 71(25): 2867-2876. DOI: 10.1016/j.jacc.2018.04.027.
[37]	Strelitz J, Ahern AL, Long GH, et al. Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality[J]. Cardiovasc Diabetol, 2019, 18(1): 98. DOI: 10.1186/s12933-019-0902-5.
[38]	Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes[J]. N Engl J Med, 2003, 348(5): 383-393. DOI: 10.1056/NEJMoa021778.
[39]	The Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial[J]. Arch Intern Med, 2010, 170(17): 1566-1575. DOI: 10.1001/archinternmed.2010.334.
[40]	The Look AHEAD Research Group, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes[J]. N Engl J Med, 2013, 369(2): 145-154. DOI: 10.1056/NEJMoa1212914.
[41]	Chudasama YV, Khunti K, Gillies CL, et al. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: a longitudinal cohort study[J]. PLoS Med, 2020, 17(9): e1003332. DOI: 10.1371/journal.pmed.1003332.